Other languages HAVN Life Sciences Inc.

Equities

HAVN

CA4196213058

Market Closed - Canadian Securities Exchange Other stock markets 19:12:37 09/11/2023 GMT			5-day change	1st Jan Change
0.03 ^CAD	-.--%		+20.00%	-.--%

2023	HAVN Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	CI
2023	HAVN Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HAVN Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	05/04/23
HAVN Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	26/01/23
HAVN Life Sciences Inc. Announces Retail Listing with Loblaws Company Ltd	27/10/22
HAVN Life Sciences Inc. Announces Board Changes	14/10/22
Havn Life Sciences Inc. Announces Departure of Mr. Tim Laidler as A Director	29/09/22
HAVN Life Sciences Inc. Reports Earnings Results for the First Quarter Ended July 31, 2022	27/09/22
HAVN Life Sciences Inc. Auditor Raises 'Going Concern' Doubt	28/08/22
HAVN Life Sciences Inc. Reports Earnings Results for the Full Year Ended April 30, 2022	28/08/22
HAVN Life Sciences Inc. Enters Supply Agreement with MPB Group Inc	28/06/22
HAVN Life Sciences Inc. Announces Board Changes	14/06/22
Havn Life Sciences Inc.: HAVN Life unterzeichnet eine Liefervereinbarung mit dem lizenzierten jamaikanischen Cannabisproduzenten Green Stripe Naturals Ltd.	07/06/22
HAVN Life Sciences Inc. Signs Supply Agreement with Licenced Jamaican Cannabis Producer, Green Stripe Naturals Ltd	07/06/22
Havn Life Sciences Inc.: HAVN Life schließt strategische Partnerschaft mit der gemeinnützigen Koalition TheraPsil	16/05/22
Havn Life Sciences Inc.: HAVN Life sichert sich Liefervereinbarung mit Atman Retreats	11/05/22
HAVN Life Sciences Inc. Secures Supply Agreement with Atman Retreats	10/05/22
Havn Life Sciences Inc.: HAVN Life liefert erste Bestellung von White-Label-Produkten an Vertriebspartner Woke Pharmaceuticals in Australien	02/05/22
Havn Life Ships First White Label Order to Distribution Partner Woke Pharmaceuticals in Australia	02/05/22
Havn Life Sciences Inc.: HAVN Life bringt seine Produktserie Brain Evolve auf den Markt	13/04/22
HAVN Life Sciences Inc. Launches the Brain Evolve Series	13/04/22
HAVN Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2022	01/04/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages HAVN Life Sciences Inc.

Equities

HAVN

CA4196213058

Other languages

Filters